As of 2025-07-08, the Relative Valuation of 9 Meters Biopharma Inc (NMTR) is (36.15) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 USD, the upside of 9 Meters Biopharma Inc based on Relative Valuation is -50169.2%.
The range of the Relative Valuation is (36.78) - (34.61) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 18.5x | 18.2x |
| Forward P/E multiples | 19.7x - 21.3x | 20.4x |
| Fair Price | (36.78) - (34.61) | (36.15) |
| Upside | -51037.2% - -48031.7% | -50169.2% |
| Date | P/E |